INTRODUCTION
============

Cardiorespiratory fitness is an element of physical fitness requiring a combination of the circulatory, respiratory, and muscular systems to supply oxygen to the working tissues during physical activity \[[@ref1]\]. There is a considerable body of evidence suggesting that poor CRF is associated with increased risks of morbidity and mortality in men and women through cardiovascular and metabolic risk factors \[[@ref2]\]. VO~2~max is the main indicator used for assessing cardiopulmonary capacity and determining respiratory circulation functions such as exercise intensity \[[@ref3]\]. The magnitude of VO~2~max is dependent on the transport of oxygen by the cardiorespiratory system from the atmosphere to exercising muscles, followed by the utilization of oxygen by metabolically active tissue \[[@ref4]\]. To accurately determine VO~2~max, a subject is required to perform a maximal test to exhaustion and oxygen consumption is measured by indirect calorimetry. Such tests are normally carried out in laboratories while subjects exercise on a treadmill or cycle ergometer. Maximal tests have practical limitations. For example, the measurement of VO~2~max is expensive, requires a high level of technical experience and supervision, and is time-consuming and impractical outside of the laboratory and in the field. Furthermore, powerful motivation is required for a subject to achieve exhaustion under high-intensity load that is not appropriate for individuals who do not have an exercise habit, the elderly, or those with diseases \[[@ref5]\]. As a result, investigators have attempted to accurately predict VO~2~max using a variety of more convenient modalities \[[@ref6]-[@ref14]\]. This has resulted in a proliferation of submaximal tests to predict CRF, which overcome many limitations of direct tests. Consequently, sub-maximal exercise testing is frequently used to estimate VO~2~max when time is limited, laboratory equipment is unavailable, or high-intensity exercises are deemed unsafe \[[@ref15]-[@ref17]\]. Submaximal exercise refers to non-exhaustive exercise that disturbs homeostasis by increasing the metabolic rate. An exercise intensity below 85 percent of age-predicted maximum heart rate is considered to be submaximal \[[@ref18]\]. Submaximal tests in the laboratory usually involve one of three modes of exercise: running, cycling, or stepping on a treadmill or cycle ergometer, or they may involve stepping up and down off of a bench. The tests are either single stage or multistage protocols.

Step tests were among the earliest submaximal tests designed to predict VO~2~max \[[@ref6]\], and have advantages over other submaximal tests. There are wide ranges of step-test protocols that differ in stepping frequency, test duration, and number of test stages \[[@ref19]\], but the main purpose of all step tests is to assess CRF. One popular step test is the YMCA 3MST \[[@ref20]\], but it is only intended to assess cardiorespiratory fitness, and not to estimate VO~2~max.

In 2014, the Korean Institute of Sport Science (KISS) conducted a study with a large sample (N = 661) and developed an equation for estimating VO~2~max using the YMCA 3MST (male: *r*^2^ = 0.429, SEE = 5.236 mL • kg^-1^ • min^-1^; female *r*^2^ = 0.439, SEE = 4.35 mL • kg^-1^ • min^-1^) intended for use in Koreans from 19 to 64 years old \[[@ref21]\]. But no studies have generalized this equation to other settings. In Vietnam, where the highly trained personnel and experimental equipment required to directly measure VO~2~max are scarce, simple tests like this are necessary. Thus, in this study we aimed to verify the validity of the equation estimating VO~2~max using the YMCA 3MST equation, and to determine whether the equation designed for Koreans was suitable for Vietnamese subjects.

MATERIALS AND METHODS
=====================

1. Subjects
-----------

The study subjects were recruited and selected among participants in the Clinical Trials Center for Functional Foods (CTCF2) at Chonbuk National University Hospital from September to October 2019. All subjects provided written informed consent before entering the study. The Helsinki Declaration guidelines were applied in this study, and the Chonbuk National University (CBNU) Institutional Review Board (IRB) approved all protocols (approval No.: 2019-07-004-005); the approval was subsequently transferred to the CBNU IRB. This clinical trial protocol was registered at the Clinical Research Information Service of Republic of Korea (<https://cris.nih.go.kr/cris/en/>; board approval number: KCT0004656).

The criteria for selection and exclusion of participants in this study are described below.

Inclusion criteria:

1.  1\) Healthy Korean and Vietnamese adults between 19 and 35 years of age at the time of screening.

2.  2\) Subjects who did not answer "Yes" to any questions on the Physical Activity Readiness Questionnaire (PAR-Q).

3.  3\) Subjects who fully understood the test and decided to participate of their own free will and agreed with the written consent document.

Exclusion criteria:

1.  1\) Subjects with cardiovascular and pulmonary disease, hypertension, orthopedic disabilities, pregnancy, or who were taking beta blocker or beta agonist asthma medications.

2.  2\) Subjects who did not abstain from caffeine or alcohol for 24 hours, food for 2 hours, and strenuous exercise for the 10 hours prior to the test.

3.  3\) Subjects who required antipsychotic medication within 2 months before the screening test.

2. Study protocol
-----------------

All subjects underwent screening tests within 4 weeks before the first visit. On the first day the subjects were reviewed and enrolled in the study and the YMCA 3-minute step test was conducted. The next day, subjects underwent the treadmill test according to the Bruce protocol ([Fig. 1](#F1){ref-type="fig"}). Tests were performed between 9:30 a.m. and 5:30 p.m. The age, height, and weight of each subject was recorded. Body mass index (BMI) was calculated as kg/m^2^. Before testing, each subject's heart rate and blood pressure were measured automatically by machine (OMRON HBP-9020, Omron Healthcare Co., Ltd., Kyoto, Japan) to ensure measurement of their baseline state.

3. Outcome measurements
-----------------------

### 1) YMCA 3-minute step test

Each test starts with a 2-minute resting phase while subjects are seated on a chair in a quiet temperature- and humidity-controlled room. Subjects are required to step up and down on a 30 cm box 72 times in 3 minutes (step up-up- down-down). Stepping frequency is indicated by a metronome set at 96 beats per minute (4 clicks = one step cycle) for a stepping rate of 24 steps per minute. The subject immediately stops upon completion of the test and then sits down and remains still. After 5 seconds, the subjects heart rate is monitored for one minute. Finally, subjects remain seated during a 5-minute recovery phase. VO~2~max was calculated using an equation formulated by the Korean Institute of Sport Science as follows:

Males: VO~2~max = 70.597 - 0.246 × (Age) + 0.077 × (Height) - 0.222 × (Weight) - 0.147 × (HR)

Females: VO~2~max = 70.597 - 0.185 × (Age) + 0.097 × (Height) - 0.246 × (Weight) - 0.122 × (HR)

Equation 1

### 2) Treadmill exercise stress test

Each subject warmed up for one minute by walking on the treadmill at their own pace at a 0% gradient. Speed and incline were increased according to the Bruce protocol \[[@ref22]\] until the subject was unable to continue with the test grade. VO~2~max was measured using the same breath-by-breath analysis system during the test (VMAX29, Sensormedics, CA, USA).

Oxygen uptake was considered maximal if any two of the following criteria were met: plateau in oxygen consumption with increasing work, respiratory exchange ratio ≥ 1.1, heart rate at or near age-predicted maximum (220 - age ± 10 beats/min).

### 3) Safety analysis

Safety outcomes were assessed by documenting adverse events during the overall clinical study period. Blood was collected after subjects had fasted for more than 12 h overnight. The blood was centrifuged at 3,000 rpm (Hanil Science Industrial Co., Ltd., Seoul, Korea) for 20 min and kept frozen at -80℃ until analysis. Laboratory tests (blood and urinalysis) were conducted and liver enzyme indexes of GGT, ALT, AST and total bilirubin, were analyzed with an ADVIA 2400 chemistry system (SIEMENS, Munich, Germany). ECG, vital signs, and anthropometric parameters (data not shown) were also evaluated.

### 4) Statistical analyses

All statistical analyses were performed using SAS^Ⓡ^ version 9.4 (SAS Institute, Cary, NC, USA). Values were expressed as mean ± SD (standard deviation). Paired *t*-tests were used to compare VO~2~max measured during the treadmill test and VO~2~max predicted by the YMCA 3-minute step test equation. To assess validity, normally distributed data were analyzed with the Pearson test to determine the correlation coefficient between measured VO~2~max and predicted by YMCA 3-minute step test. Data that were not normally distributed were analyzed with the Spearman test. Bland and Altman analysis was performed to assess agreement between measured and predicted VO~2~max. Statistical significance was determined at the level of p \< 0.05.

RESULTS
=======

1. Demographic characteristics
------------------------------

The general characteristics of the subjects included in this study are presented in [Table 1](#T1){ref-type="table"}. The average age was 25.7 ± 1.9 years, but the VN group was older than the KR group (p = 0.039). Weight, BMI, blood pressure, pulse, blood glucose and lipid profiles, drinking history, and smoking history did not differ significantly between the two groups.

Thirty subjects voluntarily provided written consent and were screened for this study, and all 30 were selected following evaluations of suitability for the study. No one was allowed to drop out or violate the research plan during the study, and all 30 registered subjects completed all of the study procedures ([Fig. 1](#F1){ref-type="fig"}).

2. Exercise tests
-----------------

The groups did not differ in the remaining variables. In the KR group, the mean predicted VO~2~max using the YMCA 3MST was significantly greater than the TM VO~2~max. However, VO~2~max was similar between tests in the VN group ([Fig. 2](#F2){ref-type="fig"}). The pooled (KR and VN) mean VO~2~max predicted using the YMCA 3MST was 39.20 ± 4.74 mL.kg^-1^.min^-1^, which was significantly greater than the TM VO~2~max (36.94 ± 5.46 mL.kg^-1^.min^-1^, p = 0.001). In the KR group, the mean VO~2~max predicted using the YMCA 3MST was 39.08 ± 4.66 mL.kg^-1^.min^-1^, which was significantly greater than the TM VO~2~max (35.72 ± 4.83 mL.kg^-1^.min^-1^, p = 0.0006). In the VN group, the mean predicted VO~2~max using the YMCA 3MST was 39.32 ± 4.98 mL.kg^-1^.min^-1^, which was similar to the TM VO~2~max (38.16 ± 5.94 mL.kg^-1^.min^-1^, p = 0.063).

3. Correlations between VO~2~max measured during the treadmill test and VO~2~max predicted using the YMCA 3MST equation
-----------------------------------------------------------------------------------------------------------------------

There was a strong correlation between VO~2~max predicted using the YMCA 3MST equation and direct measurements of VO~2~max made during the maximal treadmill test study (r = 0.80, p \< 0.0001, [Fig. 3a](#F3){ref-type="fig"}). This relationship remained strong in each group (KR, r = 0.81, p \< 0.001; VN, r = 0.93, p \< 0.0001, [Fig. 3b, 3c](#F3){ref-type="fig"}).

4. Differences between VO~2~max values vs. their means
------------------------------------------------------

The Bland-Altman plot is presented in [Fig. 4](#F4){ref-type="fig"}, and it further demonstrates acceptable agreement between tests in both groups. The mean difference between measured and predicted VO~2~max is 1.17 mL/kg/min with a 95% confidence interval (CI) of -0.07 to 2.40 mL/kg/min in the VN group. Systematic bias was observed between VO~2~max tests, indicating higher values in the predictive vs. maximal test in the KR group (mean difference = 3.36 mL/kg/min).

5. Safety analysis
------------------

Safety outcomes were assessed by assessing adverse events during the clinical study period as indicated by laboratory tests (blood and urinalysis), ECG, vital signs, and anthropometric parameters (data not shown). No serious adverse events were reported during the study period. The parameters of the safety assessments were within the normal range, and no subjects withdrew because of adverse events ([Table 2](#T2){ref-type="table"}).

DISCUSSION
==========

The current study confirmed the validity of the VO~2~max prediction equation developed by the YMCA 3MST for use in adults Korean and Vietnamese healthy. Our objective was to enable the use of predictive equations for fitness assessment in lieu of the maximum exercise test, which may allow clinicians to more frequently prescribe exercise for improving health.

Beutner previously reported a strong correlation between VO~2~max values predicted from a linear regression model including age, sex, and 1-minute heart beat count (HBC) from the YMCA 3MST, and actual measurements of VO~2~max during the treadmill test (r = 0.86) \[[@ref23]\]. In the present study, the VO~2~max predicted using the YMCA 3MST equation had a correlation of r = 0.80 with a VO~2~max measured using the treadmill test, therefore agreeing with the previous reported study \[[@ref23]\]. This directly indicates a strong linear relationship between the prediction and measurement of VO~2~max and confirm the applicability of the YMCA 3MST equation to the study sample. The Bland and Altman plot \[[@ref24],[@ref25]\], was used to determine the limits of agreement between measured and predicted VO~2~max, and showed that 95% of the differences between measured and predicted VO~2~max lie within the limits of agreement, which were -3.21 mL.kg^-1^.min^-1^ and 7.73 mL.kg^-1^.min^-1^. The limits of agreement are narrow enough that the YMCA 3MST equation can be used confidently for the prediction of VO~2~max in the study population in lieu of the complicated and exhaustive procedure for direct measurement of VO~2~max. In the KR group, a significant mean difference indicates that the YMCA 3MST slightly over predicts TM VO~2~max (3.36 mL/kg/min), while in VN group there was no difference between the YMCA 3MST-predicted VO~2~max and TM VO~2~max (mean difference = 1.17 mL/kg/min, p\>0.05). Additionally, although a moderately high correlation coefficient was observed in the KR group (r = 0.81), it was lower than that observed in VN group (r = 0.93). We have no clear explanation for why VO~2~max was slightly better predicted in the VN group than in the KR group based on a mean difference that was not different from zero, and a higher correlation coefficient. There are some limitations to this study. Although the findings of the present study indicate that the YMCA 3MST equation is suitable for the prediction of aerobic capacity among healthy Korean and Vietnamese adults, it remains questionable whether the YMCA 3MST is also applicable to other groups of different age, health status, or other factors. The YMCA 3MST may not be suitable for use in all subjects. The YMCA 3MST equation for VO~2~max prediction is based on post-test heart rate. Therefore, for subjects in whom heart rate does not respond typically to physical exertion, including those using heart rate-regulating medications (e.g., beta blockers) or atrial fibrillation, the equation would not obtain a valid VO~2~max prediction. Besides this, completion of the stepping test requires moderate physical exertion. It may therefore not be appropriate for populations in which exercise is not advisable or with orthopedic problems (such as knee or hip arthritis) that limit the ability to climb stairs. More research is warranted to examine the validity of the YMCA 3MST prediction equation in various clinical populations (e.g., obese individuals and individuals with diabetes).

CONCLUSION
==========

The YMCA 3MST equation is a valid sub-maximal test for the prediction of maximum aerobic capacity in Koreans, and can be adapted to predicting VO~2~max in healthy Vietnamese adults. With its useful features (convenience, low cost, safety, and ease of use), the YMCA 3MST equation is suitable to be used in clinical or community settings, allowing a wide range of health professionals in various facilities to prescribe exercise for health benefits.

![Flow diagram of the participants in this study.](JLM-10-021-f1){#F1}

![Differences between VO~2~max measured during the treadmill test and VO~2~max predicted using the equation from the YMCA 3-minute step test.\
Value: means ± SD, ns: no significant difference, \*\*\* Significant difference with p \< 0.001.](JLM-10-021-f2){#F2}

![The relationship between measured VO~2~max from treadmill test and predicted VO~2~max using equation from the YMCA 3-minute step test. (a) total, (b) Korean group, (c) Vietnamese group.](JLM-10-021-f3){#F3}

![Agreement plot of the difference in predicted VO~2~max and measured VO~2~max (Equation by YMCA 3-minute step test - Treadmill test). The solid line represents the mean difference (bias) of the measured and estimated VO~2~max. The upper and lower dashed lines are limits of agreement between two testing methods. (a) Total, (b) Korean group, (c) Vietnamese group.](JLM-10-021-f4){#F4}

###### 

Baseline demographic and clinical characteristics of subjects

                                                  KR Group (n = 15)   VN Group (n = 15)   Total (N = 30)   p-value[\*](#t1f2){ref-type="table-fn"}
  ----------------------------------------------- ------------------- ------------------- ---------------- -----------------------------------------
  Age (years)                                     25.0 ± 1.6          26.4 ± 2.0          25.7 ± 1.9       0.039[†](#t1f3){ref-type="table-fn"}
  Sex (M/F)                                       7/8                 7/8                 14/16            \> 0.999[†](#t1f3){ref-type="table-fn"}
  Weight (kg)                                     65.3 ± 15.6         57.7 ± 10.0         61.5 ± 13.4      0.124
  Height (cm)                                     169.5 ± 11.5        163.4 ± 7.8         166.5 ± 10.1     0.097
  BMI (Kg/m^2^)                                   22.4 ± 3.3          21.5 ± 2.9          22.0 ± 3.1       0.436
  SBP (mmHg)                                      119.7 ± 15.6        119.1 ± 13.4        119.4 ± 14.3     0.911
  DBP (mmHg)                                      71.9 ± 9.0          73.6 ± 9.0          72.8 ± 8.9       0.617
  Heart rate (BPM)                                76.0 ± 7.3          79.6 ± 11.8         77.8 ± 9.8       0.325
  Alcohol (Y/N)                                   8/7                 7/8                 15/15            \> 0.999[†](#t1f3){ref-type="table-fn"}
  Alcohol (unit)[‡](#t1f4){ref-type="table-fn"}   8.5 ± 9.3           1.6 ± 0.8           5.3 ± 7.5        0.076
  Smoking (Y/N)                                   3/12                0/15                3/27             0.068[†](#t1f3){ref-type="table-fn"}
  Smoking (unit)                                  8.7 ± 1.2                               8.7 ±1.2         
  Treadmill test                                                                                           
  VO~2~max                                        35.72 ± 4.83        38.16 ± 5.94        36.94 ± 5.46     0.227
  RER                                             1.25 ± 0.08         1.25 ± 0.07         1.25 ± 0.08      0.891
  HR max                                          189.93 ± 8.84       192.40 ± 6.38       191.17 ± 7.67    0.388
  RPE                                             17.67 ± 0.98        16.80 ± 0.77        17.23 ± 0.97     0.015
  YMCA test                                                                                                
  VO~2~max                                        39.08 ± 4.66        39.32 ± 4.98        39.20 ± 4.74     0.888

Values are presented as mean ± SD or number.

^\*^Analyzed by independent t-test.

^†^Analyzed by chi-square test.

^‡^Alcohol 1 u nit = Alcohol 10 g = A lcohol 1 2.5 mL.

KR: Koreans, VN: Vietnamese, BMI: Body mass index, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, RER: Respiratory exchange ratio, HR: Heart rate, RPE: Rating of perceived exertion.

###### 

Laboratory profiles of subjects

  Laboratory profiles (standard range)   KR Group (n = 15)   VN Group (n = 15)   Total (N = 30)    p-value[\*](#t2f2){ref-type="table-fn"}
  -------------------------------------- ------------------- ------------------- ----------------- -----------------------------------------
  Hematology                                                                                       
  WBC (4.8-10.8 × 10^3^/*μ*L)            6.04 ± 0.95         6.34 ± 1.08         6.19 ± 1.01       0.423
  RBC (4.7-6.1 × 100^3^/*μ*L)            4.70 ± 0.49         4.94 ± 0.57         4.82 ± 0.54       0.220
  Hemoglobin (13-18 g/dL)                14.34 ± 1.46        14.49 ± 1.62        14.42 ± 1.52      0.787
  Hematocrit (42-52 %)                   42.31 ± 3.73        42.69 ± 4.17        42.50 ± 3.89      0.798
  Platelet (130-450 × 10^3^/*μ*L)        234.67 ± 32.09      253.20 ± 53.52      243.93 ± 44.37    0.260
  Biochemistry                                                                                     
  GGT (12-73 IU/L)                       21.53 ± 12.84       20.53 ± 8.70        21.03 ± 10.79     0.805
  AST (12-33 IU/L)                       25.13 ± 9.64        21.67 ± 5.92        23.40 ± 8.06      0.245
  ALT (5-35 IU/L))                       26.40 ± 21.24       21.27 ± 8.53        23.83 ± 16.12     0.392
  Total bilirubin (0.2-1.2 mg/dL)        0.88 ± 0.33         0.72 ± 0.20         0.80 ± 0.28       0.121
  Total protein (6.7-8.3 g/dL)           7.18 ± 0.19         7.19 ± 0.30         7.19 ± 0.25       0.886
  Albumin (3.5-5.3 g/dL)                 4.73 ± 0.24         4.67 ± 0.21         4.70 ± 0.23       0.475
  BUN (8-23 mg/dL)                       12.73 ± 2.58        13.20 ± 3.30        12.97 ± 2.92      0.669
  Creatinine (0.7-1.7 mg/dL)             0.74 ± 0.14         0.76 ± 0.16         0.75 ± 0.15       0.704
  Total cholesterol (\~200 mg/dL)        174.07 ± 33.15      179.47 ± 30.25      176.77 ± 31.30    0.645
  Triglyceride (\~200 mg/dL)             103.00 ± 48.62      89.47 ± 54.90       96.23 ± 51.41     0.481
  HDL-cholesterol (41.5-67.3 mg/dL)      57.13 ± 10.41       52.33 ± 13.84       54.73 ± 12.28     0.292
  LDL-cholesterol (0-140 mg/dL)          106.27 ± 31.68      121.33 ± 32.04      113.80 ± 32.23    0.206
  Glucose (74-106 mg/dL)                 81.27 ± 8.54        79.67 ± 5.15        80.47 ± 6.98      0.539
  Creatine Kinase 46-171 IU/L)           130.20 ± 137.40     140.60 ± 81.96      135.40 ± 111.29   0.803
  Urinalysis                                                                                       
  SG (1.005-1.030)                       1.02 ± 0.00         1.02 ± 0.01         1.02 ± 0.01       0.038
  pH (4.5-9.0)                           5.67 ± 0.52         6.43 ± 0.94         6.05 ± 0.84       0.010

Values are presented as mean ± SD.

^\*^Analyzed by independent t-test.

KR: Koreans, VN: Vietnamese, WBC: White Blood Cell, RBC: Red Blood Cell, ALP: Alkaline Phosphatase, GGT: Gamma Glutamyl

Transferase, AST: Aspartate Transaminase, ALT: Alanine Transaminase, BUN: Blood Urea Nitrogen.
